검색어 : 통합검색[Weil Terence]
총 8건 중 8건 출력
, 1/1 페이지
-
1
- Evaluating the demand for supergauge trucks-on-trains services in Western Europe
- Higginson, John; Hogan, Terence; Weil, Mark; ; (European journal of operational research, v.97, 1997, pp.293-307)
-
2
- Die Geschichte der Prostatektomie – Von den Anfängen bis DaVinci
- Hatzinger, M.; Hubmann, R.; Moll, F.; Sohn, M.; Urologische Abteilung, Hamburg; Urologische Abteilung, Klinikum Holweide, Kö ln; Urologische Abteilung, Markuskrankenhaus Frankfurt; (Aktuelle Urologie, v.43, 2012, pp.228-230)
-
3
- Complementary and alternative medicine exposure in oncology (CAMEO) study: A multi-institutional cross-sectional analysis of patients receiving cancer treatment.
- Hutten, Ryan J.; Weil, Christopher R.; Barney, Brandon M.; Fagerlin, Angela; Gaffney, David K.; Gill, David Michael; Whipple, Gary; Rhodes, Terence Duane; Scherer, Laura; Suneja, Gita; Tward, Jonathan David; Werner, Theresa Louise; Evans, Jaden; Johnson, Skyler B; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Intermountain Health Care, Provo, UT; ; University of Utah School of Medicine, Salt Lake City, UT; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Intermountain Healthcare, Murray, UT; ; Browning Cancer Center, Ogden, UT; ; Intermountain Healthcare, Murray, UT; ; University of Colorado, Denver, CO; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; University of Utah, Salt Lake City, UT; ; Intermountain Cancer Centers, Logan, UT; ; Uinversity of Utah, Salt Lake City, UT; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.40, 2022, pp.e18739-e18739)
-
4
- Shifting perceptions of alternative therapies in cancer patients during the COVID-19 pandemic: Results from the Complementary and Alternative Medicine Exposure in Oncology (CAMEO) Study.
- Weil, Christopher R.; Hutten, Ryan J.; Barney, Brandon M.; Fagerlin, Angela; Gaffney, David K.; Gill, David Michael; Whipple, Gary; Rhodes, Terence Duane; Scherer, Laura; Suneja, Gita; Tward, Jonathan David; Werner, Theresa Louise; Johnson, Skyler B; Evans, Jaden D.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Intermountain Health Care, Provo, UT; ; University of Utah School of Medicine, Salt Lake City, UT; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Intermountain Healthcare, Murray, UT; ; Intermountain Healthcare, Ogden, UT; ; Intermountain Healthcare, Murray, UT; ; University of Colorado, Denver, CO; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; Intermountain Healthcare, Ogden, UT; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.40, 2022, pp.e24130-e24130)
-
5
- The lacrimal system. By Benjamin Milder and Bernardo A. Weil, 223 pp, illus, Appleton‐Century‐Crofts, Norwalk, CT, 1983. $52.50
- Davidson, Terence M.; ; (Head & neck surgery, v.6, 1984, pp.1066-1066)
-
6
- Number theory for beginners, by A. Weil (with the collaboration of M. Rosenlicht). Pp vii, 70. DM11. 1979. SBN 3 540 90381 X (Springer)
- Jackson, Terence; ; (The Mathematical gazette, v.64, 1980, pp.219-220)
-
7
- Interleukin-12 armored chimeric antigen receptor (CAR) T cells for heterogeneous antigen-expressing ovarian cancer.
- Yeku, Oladapo O.; Purdon, Terence; Spriggs, David R.; Brentjens, Renier J.; Memorial Sloan Kettering Cancer Center, New York, NY; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Memorial Sloan Kettering Cancer Center and Weil Cornell Medical College, New York, NY; ; Memorial Sloan Kettering Cancer Center, New York, NY; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.12-12)
-
8
- Chimeric antigen receptor (CAR) T cells genetically engineered to deliver IL-12 to the tumor microenvironment in ovarian cancer.
- Yeku, Oladapo O.; Purdon, Terence; Spriggs, David R.; Brentjens, Renier J.; Memorial Sloan Kettering Cancer Center, New York, NY; ; Memorial Sloan-Kettering Cancer Center, New York, NY; ; Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical College, New York, NY; ; Memorial Sloan-Kettering Cancer Center, New York, NY; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.35, 2017, pp.3050-3050)
1
QUICK MENU
